Catalyst Pharmaceutical Partners Inc buy Stephens
Start price
18.11.24
/
50%
€19.62
Target price
18.11.25
€33.11
Performance (%)
-1.83%
End price
19.11.25
€19.26
Summary
This prediction ended on 19.11.25 with a price of €19.26. With a performance of -1.83%, the BUY prediction by Stephens finished with a loss. Stephens has a follow-up prediction for Catalyst Pharmaceutical Partners Inc where he still thinks Catalyst Pharmaceutical Partners Inc is a Buy. Stephens has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | -0.396% | -0.396% | -1.324% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Stephens for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Stephens. They set an "overweight" rating and a $35.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Stephens gewählte maximale Laufzeit wurde überschritten
Current prediction by Stephens for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€22.13
27.02.25
27.02.25
€31.66
27.02.26
27.02.26
-9.08%
12.12.25
12.12.25
